GALERA THERAPEUTICS INC
COM · CUSIP 36338D108
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($3.8m this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $8.10.
Trends to Q3 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 33 |
| Q1 2020 | 35 |
| Q2 2020 | 42 |
| Q3 2020 | 45 |
| Q4 2020 | 52 |
| Q1 2021 | 55 |
| Q2 2021 | 48 |
| Q3 2021 | 41 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 17 | 12 |
| Q2 2020 | 29 | 5 |
| Q3 2020 | 12 | 16 |
| Q4 2020 | 28 | 9 |
| Q1 2021 | 25 | 20 |
| Q2 2021 | 22 | 31 |
| Q3 2021 | 14 | 20 |
Biggest buyers
| Altium Capital Management LLC | Added | +80.7k |
| AIGH Capital Management LLC | Added | +13.6k |
| STATE STREET CORP | Added | +9.9k |
| ROYAL BANK OF CANADA | Added | +7.4k |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Added | +5.2k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +4.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Added | +3.8k |
| NORTHERN TRUST CORP | Added | +3.4k |
| Worth Venture Partners, LLC | Added | +3.0k |
| Trexquant Investment LP | Added | +2.5k |
Biggest sellers
| PERCEPTIVE ADVISORS LLC | Sold out | -509.3k |
| Tekla Capital Management LLC | Reduced | -143.5k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -81.2k |
| Tibra Equities Europe Ltd | Sold out | -36.9k |
| JPMORGAN CHASE & CO | Reduced | -35.9k |
| MARSHALL WACE, LLP | Reduced | -33.5k |
| ExodusPoint Capital Management, LP | Sold out | -25.2k |
| Jump Financial, LLC | Sold out | -18.0k |
| Ergoteles LLC | Reduced | -10.4k |
| HRT FINANCIAL LP | Reduced | -9.7k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Emerald Bioventures, LLC
13D · may seek influence
+3.7 pts · filed 2026-05-29
Stated purposeItem 4 of the Original 13D is supplemented and amended, as the case may be, as follows: On May 14, 2026, the Issuer provided Emerald with a Notice of Mandatory Conversion of Series B Non-Voting Convertible Preferred Stock (the "Mandatory Conversion Notice") effective May 15, 2026 (the "Mandatory Conversion"). In connection with the Mandatory Conversion, 20,813.8186192892 shares of Series B Preferred Stock held by Emerald were converted into 20,813,818 shares of Common Stock. In lieu of fractional shares to which Emerald was entitled, the Company is required to pay Emerald an amount of cash equal to such fraction multiplied by the closing price of a share of Common Stock on the applicable Trading Market (as defined in the Certificate of Designation) on the date of the Mandatory Conversio… Full filing |
30.2% |
Hyare Parvinder Singh
13D · may seek influence
new · filed 2026-06-11
Stated purposeThe response to Item 6 of this Schedule 13D is incorporated herein by reference. Nova MergerOn December 30, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Nova Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub") and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Nova Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger … Full filing |
6.7% |
CHANG NANCY T
13D · may seek influence
new · filed 2026-04-10
Stated purposeThe responses to Items 3 and 6 of this Schedule 13D are incorporated herein by reference. Pursuant to the Agreement and Plan of Merger, dated December 30, 2024 (the "Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub"), and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger and as part of … Full filing |
5.9% |
Fell to 5% or below in the last year: Ikarian Capital, LLC (0.0%, 2026-08-14)
Holders, Q3 2021
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 0.42% of their portfolio | 4.4m $35.3m | Unchanged |
| Sofinnova Investments, Inc. 1.60% of their portfolio | 3.1m $25.0m | Unchanged |
| NOVO HOLDINGS A/S 1.03% of their portfolio | 2.5m $19.9m | Unchanged |
| AIGH Capital Management LLC 4.65% of their portfolio | 2.0m $16.5m | Added +13.6k |
| Blackstone Inc. 0.03% of their portfolio | 1.7m $13.6m | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 1.5m $12.2m | Unchanged |
| Tekla Capital Management LLC 0.23% of their portfolio | 898.4k $7.3m | Reduced -143.5k |
| Nan Fung Group Holdings Ltd 1.59% of their portfolio | 613.2k $5.0m | Unchanged |
| Rock Springs Capital Management LP 0.10% of their portfolio | 568.3k $4.6m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 481.5k $3.9m | Unchanged |
| Worth Venture Partners, LLC 1.73% of their portfolio | 472.2k $3.8m | Added +3.0k |
| Altium Capital Management LLC 0.65% of their portfolio | 300.6k $2.4m | Added +80.7k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 275.9k $2.2m | Unchanged |
| FRAZIER MANAGEMENT LLC 0.16% of their portfolio | 241.0k $2.0m | Unchanged |
| JACOBS LEVY EQUITY MANAGEMENT, INC 0.01% of their portfolio | 200.4k $1.6m | Added +5.2k |
| BlackRock Inc. 0.00% of their portfolio | 185.9k $1.5m | Added +769 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.02% of their portfolio | 113.8k $922.0k | Added +3.8k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 83.0k $673.0k | Reduced -33.5k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 75.3k $610.0k | Added +4.1k |
| Taylor Wealth Management Partners 0.17% of their portfolio | 58.0k $470.0k | Reduced -7.2k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 37.3k $302.0k | Reduced -81.2k |
| Raymond James Financial Services Advisors, Inc. 0.00% of their portfolio | 30.3k $245.0k | Unchanged |
| Ergoteles LLC 0.01% of their portfolio | 29.6k $240.0k | Reduced -10.4k |
| STATE STREET CORP 0.00% of their portfolio | 25.9k $209.0k | Added +9.9k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 23.7k $192.0k | Reduced -500 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 18.9k $154.0k | Reduced -6.2k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 18.2k $147.0k | Added +3.4k |
| HRT FINANCIAL LP 0.00% of their portfolio | 14.7k $119.0k | Reduced -9.7k |
| Trexquant Investment LP 0.01% of their portfolio | 13.7k $111.0k | Added +2.5k |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 13.0k $105.0k | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.7k $95.0k | Added +1 |
| US BANCORP \DE\ 0.00% of their portfolio | 10.6k $86.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 7.7k $62.0k | Added +7.4k |
| TCI Wealth Advisors, Inc. 0.01% of their portfolio | 6.0k $48.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 5.6k $45.0k | Reduced -293 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 3.3k $26.0k | Reduced -3 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.3k $19.0k | Added +2.1k |
| Migdal Insurance & Financial Holdings Ltd. 0.00% of their portfolio | 1.3k $11.0k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1.2k $10.0k | Reduced -791 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 51 $0 | Reduced -35.9k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |